STOCK TITAN

Kewaunee Scienti Stock Price, News & Analysis

KEQU Nasdaq

Welcome to our dedicated page for Kewaunee Scienti news (Ticker: KEQU), a resource for investors and traders seeking the latest updates and insights on Kewaunee Scienti stock.

Kewaunee Scientific Corporation (NASDAQ: KEQU) is a manufacturing company specializing in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. This news page aggregates company announcements, earnings releases, and other disclosures so readers can follow developments that affect KEQU stock and Kewaunee’s operations.

Recent news has focused on quarterly and annual financial results, where Kewaunee reports performance for its domestic, international, and corporate segments and discusses trends in sales, profitability, and order backlog. The company also provides updates on non-GAAP metrics such as EBITDA, Segment EBITDA, Adjusted EBITDA, and adjusted net earnings, including the impact of acquisition and integration costs related to NuAire.

Investors and observers can also find coverage of capital structure and financing actions, including debt refinancing, early repayment of seller notes associated with the NuAire acquisition, and amendments to loan agreements. In addition, Kewaunee issues news about share repurchase program amendments and its approach to capital allocation.

Corporate governance and strategic matters appear in items such as board appointments, proxy-related communications, and disclosures about strategic investments in people, processes, and technology at the corporate level. Operational and commercial updates include participation in industry events like the Arablab Live trade show and information about Kewaunee’s global footprint, including its manufacturing facilities in Statesville, North Carolina and Bangalore, India and its sales offices in multiple countries.

By reviewing the KEQU news feed on this page, readers can track how Kewaunee communicates about its financial performance, acquisitions, international activities, and corporate initiatives over time.

Rhea-AI Summary

Kewaunee Scientific Corporation (NASDAQ: KEQU) reported a 7.4% decline in first quarter sales, totaling $36.4 million, compared to $39.3 million last year. The company faced a pre-tax loss of $587,000, reversing from last year's earnings of $665,000. Net earnings fell 227% to a loss of $598,000, or ($0.22) per diluted share. While domestic sales grew 2.6% to $30.1 million, international sales plummeted 36.7%. Corporate expenses rose 27.6% due to increased pension expenses. Cash reserves decreased slightly to $4.8 million, with working capital at $27.8 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
-
Rhea-AI Summary

Kewaunee Scientific Corporation (Nasdaq: KEQU) will release its first quarter fiscal year 2021 financial results on September 8, 2020, after market close. The results will be available on the company’s website at www.kewaunee.com. Founded in 1906, Kewaunee specializes in laboratory, healthcare, and technical furniture products, with manufacturing facilities in North Carolina and India. The company emphasizes forward-looking statements regarding its financial condition and operational results, acknowledging risks and uncertainties that could impact actual outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
conferences earnings
-
Rhea-AI Summary

Kewaunee Scientific Corporation (NASDAQ: KEQU) has announced the establishment of a Technical Service Organization in Saudi Arabia to enhance its operations in the Middle East and Africa. This initiative aims to strengthen Kewaunee's presence and relationships with regional customers, leveraging local talent to support its growing market. The company's leadership anticipates that this move will facilitate tailored solutions and foster long-term partnerships, contributing to sustained growth in these emerging markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.11%
Tags
none
Rhea-AI Summary

Kewaunee Scientific Corporation (NASDAQ: KEQU) reported a 4Q 2020 net loss of $1,062,000, down from $1,270,000 a year earlier, with a diluted loss per share of ($0.39). 4Q sales totaled $34,257,000, a 1.4% decline year-over-year, impacted significantly by the coronavirus pandemic. Domestic sales rose 11.6% to $27,533,000, while international sales plunged 33.2% to $6,724,000. For fiscal year 2020, sales rose slightly to $147,540,000, with a net loss of $4,687,000. The company cited operational challenges from the pandemic and ongoing restructuring efforts as key factors affecting profitability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.11%
Tags
-
Rhea-AI Summary

Kewaunee Scientific Corporation (NASDAQ: KEQU) will release its fourth quarter and fiscal year-end 2020 financial results on July 21, 2020, post market close. The delay is attributed to mandated government shutdowns affecting international subsidiaries' year-end activities. Additionally, the company will hold its annual shareholder meeting virtually on August 26, 2020, due to COVID-19 related travel uncertainties. Kewaunee Scientific specializes in manufacturing laboratory and technical furniture products.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
conferences earnings

FAQ

What is the current stock price of Kewaunee Scienti (KEQU)?

The current stock price of Kewaunee Scienti (KEQU) is $34.0099 as of April 2, 2026.

What is the market cap of Kewaunee Scienti (KEQU)?

The market cap of Kewaunee Scienti (KEQU) is approximately 97.4M.

KEQU Rankings

KEQU Stock Data

97.37M
2.15M
Furnishings, Fixtures & Appliances
Laboratory Apparatus & Furniture
Link
United States
STATESVILLE

KEQU RSS Feed